RPL17 and neoplasm: The pathological evidence demonstrated infiltration of PD-L1+ TAM and CD8+ lymphocytes in the tumor environment, revealing that PD-L1 high expression in TAM might be an indicator of a positive response to anti-PD-1 antibodies [34].